PubMed | b Institute for Clinical Diabetology and a Institute for Clinical Biochemistry and Pathobiochemistry
Type: Journal Article | Journal: Archives of physiology and biochemistry | Year: 2016
Investigating complex signatures of biomolecules by mass spectrometry approaches has become indispensable in molecular life science research. Nowadays, various mass spectrometry-based omics technologies are available to monitor qualitative and quantitative changes within hundreds or thousands of biological active components, including proteins/peptides, lipids and metabolites. These comprehensive investigations have the potential to decipher the pathophysiology of disease development at a molecular level and to monitor the individual response of pharmacological treatment or lifestyle intervention.